Question 1

What is the catalog number for Fluorescent labeled microvesicles derived from human prostate adenocarcinoma (LnCAP cell line)?

Accepted Answer

The catalog number for Fluorescent labeled microvesicles derived from human prostate adenocarcinoma (LnCAP cell line) is LEV-F665-LnCAP.

Question 2

Is Fluorescent labeled microvesicles derived from human prostate adenocarcinoma (LnCAP cell line) in stock?

Accepted Answer

Fluorescent labeled microvesicles derived from human prostate adenocarcinoma (LnCAP cell line) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 4

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 5

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Fluorescent labeled microvesicles derived from human prostate adenocarcinoma (LnCAP cell line)

Product Specifications

Frequently Asked Questions

Explore Other Products

Cytokeratin, LMW (AE-1), CF405S conjugate, 0.1mg/mL

CD3e (RIV9), CF568 conjugate, 0.1mg/mL

CD47 (B6H12.2), CF568 conjugate, 0.1mg/mL

CD50 / ICAM3 (CG106), CF640R conjugate, 0.1mg/mL

TYRP1 (Tyrosinase Related Protein 1) (TA99), CF405S conjugate, 0.1mg/mL

Von Willebrand Factor (3E2D10), CF740 conjugate, 0.1mg/mL